Chan Man Wai, Haidry Rehan, Norton Benjamin, di Pietro Massimiliano, Hadjinicolaou Andreas V, Barret Maximilien, Doumbe Mandengue Paul, Seewald Stefan, Bisschops Raf, Nafteux Philippe, Bourke Michael J, Gupta Sunil, Mundre Pradeep, Lemmers Arnaud, Vuckovic Clémence, Pech Oliver, Leclercq Philippe, Coron Emmanuel, Meijer Sybren L, Bergman Jacques J G H M, Pouw Roos E
Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, Netherlands.
Cancer Centre Amsterdam, Amsterdam, Netherlands.
Endoscopy. 2025 Apr 28. doi: 10.1055/a-2538-9316.
Post-endoscopic resection (ER) management of high risk T1 esophageal adenocarcinoma (EAC) is debated, with conflicting reports on lymph node metastasis (LNM). We aimed to assess outcomes following radical ER for high risk T1 EAC.We identified patients who underwent radical ER (tumor-negative deep margin) of high risk T1 EAC, followed by surgery or endoscopic surveillance, between 2008 and 2019 across 11 international centers.106 patients (86 men; mean [SD] age, 70 [11] years) were included. Of these, 26 (age, 64 [11] years) underwent additional surgery, with residual T1 EAC found in five patients (19%) and LNM in two (8%). After a median [IQR] follow-up of 47 [32-79] months, 2/26 patients (8%) developed LNM/distant metastasis, with one EAC-related death (4%), one unrelated death (4%), and four patients lost to follow-up (15%). Of the 80 patients (age, 71 [9] years) who entered endoscopic surveillance, 5/80 (6%) developed LNM/distant metastasis, with four EAC-related deaths (5%) over 46 (IQR 25-59) months follow-up; there were 15 unrelated deaths (19%), and 10 patients lost to follow-up (13%). The overall rates (95%CI) were: LNM, 6% (2%-12%); LNM/distant metastasis, 7% (3%-13%); EAC-related mortality, 5% (2%-11%); overall mortality, 20% (95%CI 13-29).Our findings present low rates of LNM after radical ER of high risk T1 EAC, consistent with other endoscopy-focused studies. Post-surgical patients are still at risk for metastasis and disease-specific mortality. These results suggest that endoscopic surveillance is suitable for selected cases, but further prospective studies are needed to refine patient selection and confirm optimal outcomes.
内镜切除术后(ER)对高危T1期食管腺癌(EAC)的管理存在争议,关于淋巴结转移(LNM)的报道相互矛盾。我们旨在评估高危T1期EAC根治性ER后的结局。我们确定了2008年至2019年间在11个国际中心接受高危T1期EAC根治性ER(肿瘤切缘阴性)、随后接受手术或内镜监测的患者。纳入了106例患者(86例男性;平均[标准差]年龄,70[11]岁)。其中,26例(年龄,64[11]岁)接受了额外手术,5例患者(19%)发现残留T1期EAC,2例(8%)发现LNM。在中位[四分位间距]随访47[32 - 79]个月后,26例患者中有2例(8%)发生LNM/远处转移,1例EAC相关死亡(4%),1例非相关死亡(4%),4例患者失访(15%)。在80例进入内镜监测的患者(年龄,71[9]岁)中,80例中有5例(6%)发生LNM/远处转移,在46(四分位间距25 - 59)个月的随访中有4例EAC相关死亡(5%);有15例非相关死亡(19%),10例患者失访(13%)。总体发生率(95%置信区间)为:LNM,6%(2% - 12%);LNM/远处转移,7%(3% - 13%);EAC相关死亡率,5%(2% - 11%);总死亡率,20%(95%置信区间13 - 29)。我们的研究结果显示,高危T1期EAC根治性ER后LNM发生率较低,与其他以内镜检查为重点的研究一致。术后患者仍有转移和疾病特异性死亡的风险。这些结果表明,内镜监测适用于特定病例,但需要进一步的前瞻性研究来优化患者选择并确认最佳结局。